As a leading provider of specialized Immune Globulin (IgG) and other intravenous home infusion therapies, AxelaCare has the right combination of people, capabilities, experience, partners and most importantly, level of care for our patients.

AxelaCare's comprehensive capabilities and services are designed to meet the needs of each individual infusion patient. These services include:

Specialized Home Infusion
Pharmacy and Nursing
Patient Advocacy and Reimbursement Support
Immune Globulin (IgG) Therapy
Administrative Services
Treatment Management
Patient Education
Care Provider Resources
Clinical Care Research

Company Growth (employees)
Lenexa, US
Size (employees)
228 (est)-3%
AxelaCare is headquartered in Lenexa, US

Key People/Management at AxelaCare

Ted Kramm

Ted Kramm

Chief Executive Officer
Kathee Kramm

Kathee Kramm


AxelaCare Office Locations

AxelaCare has an office in Lenexa
Lenexa, US (HQ)
9801 Renner Blvd
Show all (1)

AxelaCare Financials and Metrics

Summary Metrics

Total Funding

$66 m

Latest funding size

$66 m

Time since last funding

about 7 years
AxelaCare's latest funding round in December 2010 was reported to be $66 m. In total, AxelaCare has raised $66 m

AxelaCare's Web-traffic and Trends

AxelaCare Online and Social Media Presence

AxelaCare Company Life and Culture

You may also be interested in